Successful treatment of restless legs syndrome with the herbal prescription Yokukansan

Successful treatment of restless legs syndrome with the herbal prescription Yokukansan 1 <h5>Introduction</h5> The National Institutes of Health RLS workshop (2003) defined the diagnostic criteria. Essential criteria are: (1) an urge to move, accompanied with uncomfortable sensations in the legs; (2) the urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity; (3) the urge to move or unpleasant sensations are relieved by movement; and (4) these symptoms are worse in the evening or night than during the day or occur only in the evening or night. Most RLS patients report difficulties falling asleep ( Montplaisir et al., 2005 ). It is also difficult to maintain their sleep because they awaken with unpleasant leg sensations ( Allen and Earley, 2001 ). As a consequence of frequent arousals from nocturnal sleep, patients often experience excessive daytime fatigue and somnolence. Several double-blind, placebo-controlled studies have demonstrated the superiority of pramipexole, an agonist for dopamine D2/D3 receptor, for the broad range of RLS symptoms ( Partinen et al., 2006 ). Clonazepam is prescribed to improve sleep continuity, because dopaminergic agents sometimes worsen insomnia and induce nausea. Yokukansan (YKS) was developed as a remedy for restlessness and agitation. In Japan, YKS prescription has been approved for patients with http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Progress in Neuro-Psychopharmacology & Biological Psychiatry Elsevier

Successful treatment of restless legs syndrome with the herbal prescription Yokukansan

Loading next page...
 
/lp/elsevier/successful-treatment-of-restless-legs-syndrome-with-the-herbal-tIA5ur7GMK
Publisher
Elsevier
Copyright
Copyright © 2009 Elsevier Inc.
ISSN
0278-5846
eISSN
1878-4216
D.O.I.
10.1016/j.pnpbp.2009.11.007
Publisher site
See Article on Publisher Site

Abstract

1 <h5>Introduction</h5> The National Institutes of Health RLS workshop (2003) defined the diagnostic criteria. Essential criteria are: (1) an urge to move, accompanied with uncomfortable sensations in the legs; (2) the urge to move or unpleasant sensations begin or worsen during periods of rest or inactivity; (3) the urge to move or unpleasant sensations are relieved by movement; and (4) these symptoms are worse in the evening or night than during the day or occur only in the evening or night. Most RLS patients report difficulties falling asleep ( Montplaisir et al., 2005 ). It is also difficult to maintain their sleep because they awaken with unpleasant leg sensations ( Allen and Earley, 2001 ). As a consequence of frequent arousals from nocturnal sleep, patients often experience excessive daytime fatigue and somnolence. Several double-blind, placebo-controlled studies have demonstrated the superiority of pramipexole, an agonist for dopamine D2/D3 receptor, for the broad range of RLS symptoms ( Partinen et al., 2006 ). Clonazepam is prescribed to improve sleep continuity, because dopaminergic agents sometimes worsen insomnia and induce nausea. Yokukansan (YKS) was developed as a remedy for restlessness and agitation. In Japan, YKS prescription has been approved for patients with

Journal

Progress in Neuro-Psychopharmacology & Biological PsychiatryElsevier

Published: Feb 1, 2010

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off